PRESS RELEASES

• Pharmaron Acquires Absorption Systems in the USA

  To enhance service offerings and increase presence in global markets Beijing, China, November 9, 2020 – Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”), a fully integrated contract research and manufacturing […]

• Absorption Systems’ ACF Bioservices Certified by European Agency for GMP-compliant Alternative Therapeutic Medicinal Product Stability and Product Release Testing

  Absorption Systems’ ACF Bioservices Certified by European Agency for GMP-compliant Alternative Therapeutic Medicinal Product Stability and Product Release Testing EXTON, Pa., Aug. 7, 2018 /PRNewswire/ — Absorption Systems® and its ACF Bioservices™ subsidiary announced […]

• Japanese Patent Granted for Absorption Systems’ IDAS2™, a Uniquely Predictive Test System for Fundamental Drug Properties

  Technology enables testing of drug absorption and formulation performance in a single step EXTON, Pa., Sept. 4, 2018 /PRNewswire/ — Absorption Systems, a global leader in the science of translational medicine, announces that […]

• Absorption Systems’ ACF Bioservices Certified by European Agency for GMP-compliant Alternative Therapeutic Medicinal Product Stability and Product Release Testing

  Absorption Systems’ ACF Bioservices Certified by European Agency for GMP-compliant Alternative Therapeutic Medicinal Product Stability and Product Release Testing EXTON, Pa., Aug. 7, 2018 /PRNewswire/ — Absorption Systems® and its ACF Bioservices™ subsidiary announced […]

• Absorption Systems Acquires TGA Sciences, Inc., Based in Medford, MA

  Absorption Systems Acquires TGA Sciences, Inc., Based in Medford, MA Contract R&D laboratory near Cambridge reinforces Absorption Systems’ commitment to small molecules and biologics development in addition to its expertise […]

• Absorption Systems Awarded 5-year IDIQ Contract by the FDA

  To conduct preclinical testing of locally-acting topical dermal and ophthalmic drug product formulations EXTON, PA – October 09, 2019 – Absorption Systems, a global leader in translational medicine, pharmacokinetic testing […]

• Absorption Systems Embarks on Research Collaboration with the U.S. Food and Drug Administration

  EXTON, Pa., Sept. 19, 2017 /PRNewswire/ — Absorption Systems, a global leader in translational medicine and pharmacokinetic testing of drugs, announces a formal Research Collaboration Agreement (RCA) with the U.S. […]

• Absorption Systems to Use its Proprietary IDAS Technology to Fulfill Contract Awarded by The U.S. FDA

  To conduct in vitro testing of the effects of excipients on oral drug absorption EXTON, Pa., Oct. 29, 2019 /PRNewswire/ — Absorption Systems, a global leader in translational medicine, pharmacokinetic […]

• European Patent Granted for Absorption Systems’ IDAS2™, a Uniquely Predictive Test System for Fundamental Drug Properties

  Technology enables testing of drug absorption and formulation performance in a single step EXTON, Pa., Oct. 2, 2018 /PRNewswire/ — Absorption Systems, a global leader in the science of translational medicine, announces that […]

• U.S. Patent Issued for Absorption Systems’ IDAS2™, a First-in-Class Test System for Fundamental Drug Properties

  Technology enables testing of drug absorption and formulation performance in a single step EXTON, Pa., Jan. 25, 2017 /PRNewswire/ — Absorption Systems, a global leader in the science of translational medicine, […]